In intact urethane-anesthetized rats, plasma growth hormone (GH) levels were low but increased significantly following intravenous injection of chlorpromazine. Plasma GH levels were significantly elevated in rats with hypothalamic cuts such as complete deafferentation, anterior cut and antero-lateral cut, whereas plasma GH levels in rats with posterior cut or postero-lateral cut were not significantly different from those in rats with sham-operation.
The important role of neural regulation has recently been documented in the regulation of growth hormone (GH) secretion (Miiller, 1973) . Kato et al. (1973) has demonstrated that chlorpromazine, a possible central dopamine antagonist, caused an increase in plasma GH in rats. We have confirmed these findings and extended the studies in order to clarify the mechanism by which chlorpromazine acts to regulate GH secretion (Kato et al., 1974 a, b) . Although the exact mechanism remains to be clarified, chlorpromazine possibly acts at the hypothalamus to modulate the release of either GH releasing factor (GHRF) or GH release inhibiting factor (GHRIF).
The present studies were undertaken to examine the extrahypothalamic influences regulating plasma GH response to chlorpromazine in rats. 
Materials and Methods

Discussion
Plasma GH levels were low and stable under urethane anesthesia in intact rats, compared with plasma GH levels after decapitation (Kato et al., 1973) . It may be considered that urethane has an inhibiting effect on the tonic regulation of basal GH levels in rats.
We observed that basal plasma GH levels were elevated in the rats with complete deafferentation, anterior and antero-lateral cuts. These findings suggest that inhibitory effects of urethane anesthesia are possibly transmitted through a nervous pathway which may reach the medial basal hypothalamus through an anterior route. Mitchell et al. (1973) demonstrated that surgical isolation of the medial basal hypothalamus caused marked, elevation in plasma GH levels in rats under ether anesthesia.
We reported previously that chlorpromazine induced GH release in rats and speculated that this effect was explained by a blockade of midbrain dopamine receptors or. by alpha-adrenergic blockade in the hypothalamus (Kato et al., 1973 complete hypothalamic deafferentation. Further studies in our laboratory demonstrated that plasma GH response to chlorpromazine was abolished in rats with hypothalamic lesions (Kato et al., 1974 a) . These findings suggest that chlorpromazine acts at the level of the hypothalamus.
We also demonstrated in the present Fig. 4 tion.
In our experiments, the maximum increments of plasma GH following chlorpromazine were significantly lower in rats with posterior cut, and also significantly higher in rats with antero-lateral cut than in rats with sham-operation.
No significant difference was observed between plasma GH responses to chlorpromazine in rats with posterior cut and those in rats with posterolateral cut.
These findings may indicate that the extrahypothalamic inhibitory influence on GH secretion reachs the medial basal hypothalamus through antero-lateral pathways, whereas the extrahypothalamic stimulating influence reachs posteriorly the hypothalamus. Martin (1972) and Smith et al. (1971) demonstrated the extrahypothalamic control of GH secretion in the rat and the monkey. The stimulating and inhibitory afferent inputs to the medial basal hypothalamus were also demonstrated by electrophysiological studies (Deifuss et al., 1968 ; Nauta, 1963) .
Since hypothalamic deafferentation causes a decrease of noradrenaline (Weiner, 1972) and serotonin (Popova, 1972) content in the hypothalamic island in rats, the neurons influencing GH release may contain the biogenic amines which are assumed to be involved in the regulation of release of GHRF or GHRIF (MUller, 1973) . However, the exact relationship between the biogenic amines and GHRF or GHRIF remains to be investigated.
